Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Oxidative mechanisms and tardive dyskinesia.

Lohr JB, Kuczenski R, Niculescu AB.

CNS Drugs. 2003;17(1):47-62. Review.

PMID:
12467492
2.

Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.

Elkashef AM, Wyatt RJ.

Schizophr Bull. 1999;25(4):731-40. Review.

PMID:
10667743
3.
4.

Tardive dyskinesia: eliminated, forgotten, or overshadowed?

Remington G.

Curr Opin Psychiatry. 2007 Mar;20(2):131-7. Review.

PMID:
17278910
5.

The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.

Barnes TR.

Psychiatr Dev. 1987 Winter;5(4):301-19. Review.

PMID:
2895467
6.

Treatment of tardive dyskinesia.

Egan MF, Apud J, Wyatt RJ.

Schizophr Bull. 1997;23(4):583-609. Review.

PMID:
9365997
7.

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

Andreassen OA, Jørgensen HA.

Prog Neurobiol. 2000 Aug;61(5):525-41. Review.

PMID:
10748322
8.

Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.

Pham DQ, Plakogiannis R.

Ann Pharmacother. 2005 Dec;39(12):2065-72. Epub 2005 Nov 15. Review.

PMID:
16288072
9.

Managing antipsychotic-induced tardive dyskinesia.

Gardos G.

Drug Saf. 1999 Feb;20(2):187-93. Review.

PMID:
10082074
10.

Antioxidant treatment of tardive dyskinesia.

Rotrosen J, Adler L, Lohr J, Edson R, Lavori P.

Prostaglandins Leukot Essent Fatty Acids. 1996 Aug;55(1-2):77-81. Review.

PMID:
8888127
11.

Tardive dyskinesia: review of treatments past, present, and future.

Gupta S, Mosnik D, Black DW, Berry S, Masand PS.

Ann Clin Psychiatry. 1999 Dec;11(4):257-66. Review.

PMID:
10596740
12.

Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.

Suzuki T, Matsuzaka H.

CNS Drugs. 2002;16(3):165-74. Review.

PMID:
11888337
13.

Neuroleptic-induced tardive dyskinesia.

Jenner P, Marsden CD.

Acta Psychiatr Belg. 1987 Sep-Oct;87(5):566-98. Review.

PMID:
2897761
14.

Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.

Lerner V, Miodownik C.

Curr Psychiatry Rep. 2011 Aug;13(4):295-304. doi: 10.1007/s11920-011-0202-6. Review.

PMID:
21519907
15.

Tardive dyskinesia and new antipsychotics.

Correll CU, Schenk EM.

Curr Opin Psychiatry. 2008 Mar;21(2):151-6. doi: 10.1097/YCO.0b013e3282f53132. Review.

PMID:
18332662
16.

Therapeutic strategies against tardive dyskinesia. Two decades of experience.

Jeste DV, Wyatt RJ.

Arch Gen Psychiatry. 1982 Jul;39(7):803-16. Review.

PMID:
6131655
17.

In search of treatment for tardive dyskinesia: review of the literature.

Jeste DV, Wyatt RJ.

Schizophr Bull. 1979;5(2):251-93. Review.

PMID:
37597
18.

[Utility of quetiapine in tardive dyskinesia].

Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.

Actas Esp Psiquiatr. 2003 Nov-Dec;31(6):347-52. Review. Spanish.

PMID:
14639511
19.

Progress in the treatment of tardive dyskinesia: theory and practice.

Feltner DE, Hertzman M.

Hosp Community Psychiatry. 1993 Jan;44(1):25-34. Review.

PMID:
8094705
20.

[Neuroleptic-induced movement disorders: historical perspectives].

Wolf MA, Yassa R, Llorca PM.

Encephale. 1993 Nov-Dec;19(6):657-61. Review. French.

PMID:
12404786

Supplemental Content

Support Center